BACKGROUND Empyema is the accumulation of infected fluid within the pleural cavity, sometimes accompanied by pneumothorax. Bacterial empyema is the most common. Tuberculous and fungal empyema are less common and can occur in immunocompromised patients. Empyema caused by mixed infection with both tuberculosis and fungal pathogens is even less common. CASE REPORT This report describes a 76-year-old male lung cancer patient admitted to the hospital with fever and cough. He was receiving tislelizumab immunotherapy before admission. Chest CT at admission revealed pneumonia. Following empirical antimicrobial therapy, the pneumonia showed no improvement. He refused bronchoscopy; therefore, a sputum sample was delivered for tNGS testing. Sputum tNGS testing indicated mixed infection with Acinetobacter baumannii, Stenotrophomonas maltophilia, Klebsiella pneumoniae, Streptococcus pneumoniae, Aspergillus fumigatus, Aspergillus flavus, and COVID-19. Following adjustment of the antimicrobial regimen based on pathogenetic findings, he developed empyema complicated by pneumothorax. A chest tube was inserted, resulting in improvement of empyema and pneumothorax symptoms. Bacterial, fungal, and Mycobacterium tuberculosis cultures of the pleural effusion were all negative. Further tNGS analysis of the pleural effusion revealed a mixed infection with Mycobacterium tuberculosis and Aspergillus fumigatus. The patient refused further treatment and died 5 days after discharge. CONCLUSIONS Diagnosis of tuberculous empyema and fungal empyema is challenging and the prognosis is poor. In patients with malignant tumors, particularly those receiving immunotherapy, the possibility of Mycobacterium tuberculosis infection and fungal infections should be fully considered when infections occur, and early diagnosis and treatment are essential.
{"title":"Milky Tea-Colored Pleural Effusion: Empyema Complicated by Pneumothorax Due to Mixed Infection With Mycobacterium tuberculosis and Aspergillus fumigatus.","authors":"Yaya Gong, Hongyan Sun","doi":"10.12659/AJCR.951599","DOIUrl":"10.12659/AJCR.951599","url":null,"abstract":"<p><p>BACKGROUND Empyema is the accumulation of infected fluid within the pleural cavity, sometimes accompanied by pneumothorax. Bacterial empyema is the most common. Tuberculous and fungal empyema are less common and can occur in immunocompromised patients. Empyema caused by mixed infection with both tuberculosis and fungal pathogens is even less common. CASE REPORT This report describes a 76-year-old male lung cancer patient admitted to the hospital with fever and cough. He was receiving tislelizumab immunotherapy before admission. Chest CT at admission revealed pneumonia. Following empirical antimicrobial therapy, the pneumonia showed no improvement. He refused bronchoscopy; therefore, a sputum sample was delivered for tNGS testing. Sputum tNGS testing indicated mixed infection with Acinetobacter baumannii, Stenotrophomonas maltophilia, Klebsiella pneumoniae, Streptococcus pneumoniae, Aspergillus fumigatus, Aspergillus flavus, and COVID-19. Following adjustment of the antimicrobial regimen based on pathogenetic findings, he developed empyema complicated by pneumothorax. A chest tube was inserted, resulting in improvement of empyema and pneumothorax symptoms. Bacterial, fungal, and Mycobacterium tuberculosis cultures of the pleural effusion were all negative. Further tNGS analysis of the pleural effusion revealed a mixed infection with Mycobacterium tuberculosis and Aspergillus fumigatus. The patient refused further treatment and died 5 days after discharge. CONCLUSIONS Diagnosis of tuberculous empyema and fungal empyema is challenging and the prognosis is poor. In patients with malignant tumors, particularly those receiving immunotherapy, the possibility of Mycobacterium tuberculosis infection and fungal infections should be fully considered when infections occur, and early diagnosis and treatment are essential.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e951599"},"PeriodicalIF":0.7,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12906106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146150850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carlos Eduardo Brantis-de-Carvalho, Sara Mohrbacher, Juliana Valéria Souza Framil, Victor Augusto Hamamoto Sato, Erico Souza de Oliveira, Pedro Renato Chocair
BACKGROUND Actinomycosis is an uncommon bacterial infection caused by the commensal organism Actinomyces spp., which can become pathogenic upon tissue injury or disruption of the mucosal barrier. While primarily recognized for its cervicofacial and abdominopelvic presentations, actinomycosis can also involve the gallbladder and potentially the pancreas, posing diagnostic and therapeutic challenges due to its ability to mimic other conditions. CASE REPORT We present the case of a 26-year-old woman with a history of recurrent acute pancreatitis and cholecystitis, followed by the development of thrombotic microangiopathy. An atypical hemolytic-uremic syndrome panel revealed gene mutations previously associated with the onset of this condition. Computed tomography, endoscopic ultrasound, and abdominal ultrasound revealed focal enlargement of secondary ducts in the head of the pancreas. While no gallbladder wall thickening was observed, imaging demonstrated a substantial amount of heterogeneous, predominantly hypoechoic and amorphous content within the gallbladder, suggestive of biliary sludge. The patient subsequently underwent cholecystectomy, and histopathological examination of the gallbladder specimen confirmed the presence of Actinomyces spp., observed as sulfur granules and Gram-stained bacilli, as well as varying degrees of mucosal hyperplasia, transmural fibrosis, xanthomatous histiocytes, and Rokitansky-Aschoff sinuses. CONCLUSIONS Following the procedure and appropriate antimicrobial therapy, the patient experienced resolution of the infection, improvement in overall health status, and no new episodes of pancreatitis during the following year. We propose that underlying CFHR3 and CFI gene mutations and initial systemic inflammation precipitated the thrombotic microangiopathy-atypical hemolytic uremic syndrome, and facilitated Actinomyces colonization of the compromised gallbladder, ultimately leading to chronic gallbladder disease and recurrence.
{"title":"Actinomycotic Cholecystitis and Pancreatitis: Report of an Unusual Case.","authors":"Carlos Eduardo Brantis-de-Carvalho, Sara Mohrbacher, Juliana Valéria Souza Framil, Victor Augusto Hamamoto Sato, Erico Souza de Oliveira, Pedro Renato Chocair","doi":"10.12659/AJCR.951112","DOIUrl":"10.12659/AJCR.951112","url":null,"abstract":"<p><p>BACKGROUND Actinomycosis is an uncommon bacterial infection caused by the commensal organism Actinomyces spp., which can become pathogenic upon tissue injury or disruption of the mucosal barrier. While primarily recognized for its cervicofacial and abdominopelvic presentations, actinomycosis can also involve the gallbladder and potentially the pancreas, posing diagnostic and therapeutic challenges due to its ability to mimic other conditions. CASE REPORT We present the case of a 26-year-old woman with a history of recurrent acute pancreatitis and cholecystitis, followed by the development of thrombotic microangiopathy. An atypical hemolytic-uremic syndrome panel revealed gene mutations previously associated with the onset of this condition. Computed tomography, endoscopic ultrasound, and abdominal ultrasound revealed focal enlargement of secondary ducts in the head of the pancreas. While no gallbladder wall thickening was observed, imaging demonstrated a substantial amount of heterogeneous, predominantly hypoechoic and amorphous content within the gallbladder, suggestive of biliary sludge. The patient subsequently underwent cholecystectomy, and histopathological examination of the gallbladder specimen confirmed the presence of Actinomyces spp., observed as sulfur granules and Gram-stained bacilli, as well as varying degrees of mucosal hyperplasia, transmural fibrosis, xanthomatous histiocytes, and Rokitansky-Aschoff sinuses. CONCLUSIONS Following the procedure and appropriate antimicrobial therapy, the patient experienced resolution of the infection, improvement in overall health status, and no new episodes of pancreatitis during the following year. We propose that underlying CFHR3 and CFI gene mutations and initial systemic inflammation precipitated the thrombotic microangiopathy-atypical hemolytic uremic syndrome, and facilitated Actinomyces colonization of the compromised gallbladder, ultimately leading to chronic gallbladder disease and recurrence.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e951112"},"PeriodicalIF":0.7,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12906109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mengcui Gui, Jing Lin, Yue Li, Bo Chen, Bitao Bu, Zhijun Li
BACKGROUND Multifocal acquired demyelinating sensory-motor neuropathy (MADSAM) is recognized as a variant of chronic inflammatory demyelinating polyneuropathy. The primary characteristics of MADSAM include multifocal sensory loss and muscle weakness, which are frequently asymmetrical and predominantly affect the upper limbs. Involvement of the lower limbs is less commonly observed in MADSAM. CASE REPORT A 27-year-old female patient presented with recurrent numbness and weakness in her left lower limb was admitted to our hospital. Her medical history included episodes of left peripheral facial paralysis and lower-limb numbness and weakness, which had previously improved after short-term oral steroid therapy. In addition to motor and sensory peripheral nerve impairment in the left lower limb, the neurological examination revealed atrophy of the tongue muscle and a leftward deviation of the tongue. Cerebrospinal fluid examination and magnetic resonance imaging indicated no abnormalities. Electromyography suggested demyelination of motor and sensory nerves in the left lower limb. Sural nerve biopsy demonstrated demyelination changes and axonal degeneration. A diagnosis of multifocal sensory and motor neuropathy was considered, and the patient was administered corticosteroids and tacrolimus. As the condition progressed, electromyography showed gradual involvement of both lower limbs, leading to the consideration of MADSAM. Despite treatment with corticosteroids and tacrolimus, the patient experienced relapse. Rituximab was initiated, resulting in symptoms improvement and reduced recurrence without adverse events. CONCLUSIONS Corticosteroids, plasma exchange, and immunoglobulins have been demonstrated to be effective treatments for CIDP. In our MADSAM case, rituximab proved effective when the patient did not respond to corticosteroids and tacrolimus. We propose that rituximab may serve as an alternative option for patients with MADSAM.
{"title":"Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.","authors":"Mengcui Gui, Jing Lin, Yue Li, Bo Chen, Bitao Bu, Zhijun Li","doi":"10.12659/AJCR.950084","DOIUrl":"10.12659/AJCR.950084","url":null,"abstract":"<p><p>BACKGROUND Multifocal acquired demyelinating sensory-motor neuropathy (MADSAM) is recognized as a variant of chronic inflammatory demyelinating polyneuropathy. The primary characteristics of MADSAM include multifocal sensory loss and muscle weakness, which are frequently asymmetrical and predominantly affect the upper limbs. Involvement of the lower limbs is less commonly observed in MADSAM. CASE REPORT A 27-year-old female patient presented with recurrent numbness and weakness in her left lower limb was admitted to our hospital. Her medical history included episodes of left peripheral facial paralysis and lower-limb numbness and weakness, which had previously improved after short-term oral steroid therapy. In addition to motor and sensory peripheral nerve impairment in the left lower limb, the neurological examination revealed atrophy of the tongue muscle and a leftward deviation of the tongue. Cerebrospinal fluid examination and magnetic resonance imaging indicated no abnormalities. Electromyography suggested demyelination of motor and sensory nerves in the left lower limb. Sural nerve biopsy demonstrated demyelination changes and axonal degeneration. A diagnosis of multifocal sensory and motor neuropathy was considered, and the patient was administered corticosteroids and tacrolimus. As the condition progressed, electromyography showed gradual involvement of both lower limbs, leading to the consideration of MADSAM. Despite treatment with corticosteroids and tacrolimus, the patient experienced relapse. Rituximab was initiated, resulting in symptoms improvement and reduced recurrence without adverse events. CONCLUSIONS Corticosteroids, plasma exchange, and immunoglobulins have been demonstrated to be effective treatments for CIDP. In our MADSAM case, rituximab proved effective when the patient did not respond to corticosteroids and tacrolimus. We propose that rituximab may serve as an alternative option for patients with MADSAM.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950084"},"PeriodicalIF":0.7,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12903501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammed Al Essa, Reema Aldawish, Abdullah Alkhaldi, Ghaidaa Aljbli, Thamer Althunayan, Abdullah Alkarni, Abdullah Alsalamah
BACKGROUND Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer, while medullary thyroid carcinoma (MTC) and anaplastic thyroid carcinoma (ATC) are far less common. ATC is the most aggressive form, contributing to the majority of thyroid cancer-related deaths. While the coexistence of different pathological types of thyroid malignancies has been reported, including combinations of ATC, PTC, and poorly differentiated thyroid carcinoma, the detection of ATC within extrathyroidal metastatic lymph nodes remains exceedingly rare and of notable clinical significance. CASE REPORT We present a 68-year-old woman evaluated for a progressively enlarging right-sided neck mass which was apparat in clinical examination, with no other associated symptoms or signs. Nasopharyngoscopy was unremarkable. Imaging studies revealed a large cystic and necrotic mass in the right carotid space compressing the internal jugular vein. A core needle biopsy confirmed metastatic PTC. The patient underwent total thyroidectomy with right radical neck dissection. Histopathological evaluation reported a unique combination: a collision tumor composed of PTC, infiltrative follicular subtype, and MTC. Immunohistochemistry confirmed the diagnoses, and molecular analysis revealed a BRAF mutation. The patient was not a candidate for radioactive iodine therapy due to the aggressive nature of the anaplastic component. Thus, she was referred for targeted cancer therapy. CONCLUSIONS This case highlights the synchronous occurrence of PTC, MTC, and ATC in a single patient. The localization of anaplastic transformation solely to lymph nodes without thyroidal involvement underscores the importance of meticulous histopathological assessment. Comprehensive diagnostic workup and molecular profiling are critical in guiding treatment for such complex presentations.
{"title":"Synchronous Presence of Papillary, Medullary, and Anaplastic Thyroid Tumors in a Single Patient: A Rare Case Report.","authors":"Mohammed Al Essa, Reema Aldawish, Abdullah Alkhaldi, Ghaidaa Aljbli, Thamer Althunayan, Abdullah Alkarni, Abdullah Alsalamah","doi":"10.12659/AJCR.950677","DOIUrl":"10.12659/AJCR.950677","url":null,"abstract":"<p><p>BACKGROUND Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer, while medullary thyroid carcinoma (MTC) and anaplastic thyroid carcinoma (ATC) are far less common. ATC is the most aggressive form, contributing to the majority of thyroid cancer-related deaths. While the coexistence of different pathological types of thyroid malignancies has been reported, including combinations of ATC, PTC, and poorly differentiated thyroid carcinoma, the detection of ATC within extrathyroidal metastatic lymph nodes remains exceedingly rare and of notable clinical significance. CASE REPORT We present a 68-year-old woman evaluated for a progressively enlarging right-sided neck mass which was apparat in clinical examination, with no other associated symptoms or signs. Nasopharyngoscopy was unremarkable. Imaging studies revealed a large cystic and necrotic mass in the right carotid space compressing the internal jugular vein. A core needle biopsy confirmed metastatic PTC. The patient underwent total thyroidectomy with right radical neck dissection. Histopathological evaluation reported a unique combination: a collision tumor composed of PTC, infiltrative follicular subtype, and MTC. Immunohistochemistry confirmed the diagnoses, and molecular analysis revealed a BRAF mutation. The patient was not a candidate for radioactive iodine therapy due to the aggressive nature of the anaplastic component. Thus, she was referred for targeted cancer therapy. CONCLUSIONS This case highlights the synchronous occurrence of PTC, MTC, and ATC in a single patient. The localization of anaplastic transformation solely to lymph nodes without thyroidal involvement underscores the importance of meticulous histopathological assessment. Comprehensive diagnostic workup and molecular profiling are critical in guiding treatment for such complex presentations.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950677"},"PeriodicalIF":0.7,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12903499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146150831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Min Jae Kim, Keun Soo Ahn, Tae-Seok Kim, Sunggyun Park, Hye Won Lee
BACKGROUND Acute graft-versus-host disease is a rare but highly fatal complication of liver transplantation, with a reported mortality rate exceeding 70%. Most patients are diagnosed at 3 to 6 weeks postoperatively. Early diagnosis remains challenging because of nonspecific symptoms and overlapping presentations of infections and drug reactions. CASE REPORT We report the case of a 48-year-old woman with end-stage liver disease secondary to primary biliary cholangitis who underwent deceased-donor liver transplantation. On postoperative day 16, she developed abrupt-onset anemia without bleeding, followed by a high-grade fever, erythematous rash, profuse diarrhea, and pancytopenia. Blood cultures and viral studies were negative, despite clinical deterioration. Punch biopsy of the trunk on postoperative day 20 confirmed acute graft-versus-host disease. She was treated with high-dose corticosteroids and enhanced immunosuppression but showed no improvement, meeting the criteria for steroid-refractory graft-versus-host disease. She died of multiorgan failure on postoperative day 30. This is one of the earliest biopsy-confirmed cases of graft-versus-host disease reported after deceased-donor liver transplantation. CONCLUSIONS This case highlights the importance of early clinical suspicion of graft-versus-host disease after liver transplantation, even before the full triad of symptoms manifests. Isolated anemia may be an early warning sign. Therefore, prompt histopathological confirmation via skin biopsy is essential. Current treatment strategies for steroid-refractory graft-versus-host disease are limited, underscoring the need for further therapeutic advances.
{"title":"Acute Graft-Versus-Host Disease After Deceased-Donor Liver Transplantation: A Case Report.","authors":"Min Jae Kim, Keun Soo Ahn, Tae-Seok Kim, Sunggyun Park, Hye Won Lee","doi":"10.12659/AJCR.951031","DOIUrl":"10.12659/AJCR.951031","url":null,"abstract":"<p><p>BACKGROUND Acute graft-versus-host disease is a rare but highly fatal complication of liver transplantation, with a reported mortality rate exceeding 70%. Most patients are diagnosed at 3 to 6 weeks postoperatively. Early diagnosis remains challenging because of nonspecific symptoms and overlapping presentations of infections and drug reactions. CASE REPORT We report the case of a 48-year-old woman with end-stage liver disease secondary to primary biliary cholangitis who underwent deceased-donor liver transplantation. On postoperative day 16, she developed abrupt-onset anemia without bleeding, followed by a high-grade fever, erythematous rash, profuse diarrhea, and pancytopenia. Blood cultures and viral studies were negative, despite clinical deterioration. Punch biopsy of the trunk on postoperative day 20 confirmed acute graft-versus-host disease. She was treated with high-dose corticosteroids and enhanced immunosuppression but showed no improvement, meeting the criteria for steroid-refractory graft-versus-host disease. She died of multiorgan failure on postoperative day 30. This is one of the earliest biopsy-confirmed cases of graft-versus-host disease reported after deceased-donor liver transplantation. CONCLUSIONS This case highlights the importance of early clinical suspicion of graft-versus-host disease after liver transplantation, even before the full triad of symptoms manifests. Isolated anemia may be an early warning sign. Therefore, prompt histopathological confirmation via skin biopsy is essential. Current treatment strategies for steroid-refractory graft-versus-host disease are limited, underscoring the need for further therapeutic advances.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e951031"},"PeriodicalIF":0.7,"publicationDate":"2026-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146138000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND In coronary artery bypass grafting, hyperthyroidism with autoantibodies, as seen in Basedow disease, is uncommon and rarely leads to severe thyrotoxicosis. However, surgery can trigger this condition, and documented cases have resulted in poor outcomes. We describe the case of an incidental hyperthyroidism finding on preoperative evaluation for coronary artery bypass grafting for triple-vessel coronary artery disease. CASE REPORT A 58-year-old man presented with exertional dyspnea, chest pain, and postprandial vomiting. Coronary angiography revealed severe triple-vessel disease. After admission, he experienced additional episodes of chest pain, which required continuous infusion of coronary vasodilators and strict bed rest. Preoperative screening showed severe hyperthyroidism. Thiamazole 80 mg/day and potassium iodide 50 mg/day were initiated but discontinued after 2 weeks because of leukopenia (white blood cell count, 2800×10⁹/L). Although thyroidectomy was considered, coronary artery bypass grafting was prioritized owing to cardiac risk concerns. Perioperative management included continuous hemodiafiltration dialysis, methylprednisolone (1000 mg/day), and slow plasma exchange, starting with surgery to prevent thyroid storm. Intravenous gamma globulin was administered 3 days before and after surgery. Free triiodothyronine and free thyroxine were normalized on postoperative days 3 and 7, respectively. The postoperative course was uneventful, and the patient remained symptom-free at 1-year follow-up. CONCLUSIONS Coronary artery bypass grafting with uncontrolled hyperthyroidism is prone to complications, and a thyroid storm can be fatal. Although surgery should be avoided in cases of uncontrolled hyperthyroidism, in rare cases in which urgent treatment is not feasible, a critical intervention as described in this report may prevent thyroid crisis.
{"title":"Coronary Artery Bypass Grafting in the Presence of Severe Hyperthyroidism: A Case Report.","authors":"Akie Shimada, Taira Yamamoto, Jiyoung Lee, Shizuyuki Dohi, Daisuke Endo, Yuichiro Sato, Yasutaka Yokoyama, Minoru Tabata","doi":"10.12659/AJCR.950442","DOIUrl":"10.12659/AJCR.950442","url":null,"abstract":"<p><p>BACKGROUND In coronary artery bypass grafting, hyperthyroidism with autoantibodies, as seen in Basedow disease, is uncommon and rarely leads to severe thyrotoxicosis. However, surgery can trigger this condition, and documented cases have resulted in poor outcomes. We describe the case of an incidental hyperthyroidism finding on preoperative evaluation for coronary artery bypass grafting for triple-vessel coronary artery disease. CASE REPORT A 58-year-old man presented with exertional dyspnea, chest pain, and postprandial vomiting. Coronary angiography revealed severe triple-vessel disease. After admission, he experienced additional episodes of chest pain, which required continuous infusion of coronary vasodilators and strict bed rest. Preoperative screening showed severe hyperthyroidism. Thiamazole 80 mg/day and potassium iodide 50 mg/day were initiated but discontinued after 2 weeks because of leukopenia (white blood cell count, 2800×10⁹/L). Although thyroidectomy was considered, coronary artery bypass grafting was prioritized owing to cardiac risk concerns. Perioperative management included continuous hemodiafiltration dialysis, methylprednisolone (1000 mg/day), and slow plasma exchange, starting with surgery to prevent thyroid storm. Intravenous gamma globulin was administered 3 days before and after surgery. Free triiodothyronine and free thyroxine were normalized on postoperative days 3 and 7, respectively. The postoperative course was uneventful, and the patient remained symptom-free at 1-year follow-up. CONCLUSIONS Coronary artery bypass grafting with uncontrolled hyperthyroidism is prone to complications, and a thyroid storm can be fatal. Although surgery should be avoided in cases of uncontrolled hyperthyroidism, in rare cases in which urgent treatment is not feasible, a critical intervention as described in this report may prevent thyroid crisis.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950442"},"PeriodicalIF":0.7,"publicationDate":"2026-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146132400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muyin Feng, Qili Xiao, Delong Mo, Yuting Xu, Yan Chen, Chuanjian Lu
BACKGROUND Filiform polyposis (FP) is a rare pseudopolyp associated with inflammatory bowel disease (IBD), characterized by elongated mucosal projections. It is found primarily in the colon and rectum, and presentation in the ileum is rare. Despite its benign nature, FP can mask underlying chronic intestinal inflammation. CASE REPORT A 52-year-old woman presented with loose stool but no other gastrointestinal symptoms. She was found to have a branched mucosal mass in the terminal ileum and diffuse ulcerations throughout the colorectum. Initial laboratory tests indicated anemia and elevated inflammatory markers. After 3 months of treatment with mesalazine and adjuvant drugs, the symptom of loose stool had improved, but the colonoscopy and imaging examination results show little change from the initial visit. Colonoscopy, imaging, and histopathology supported a diagnosis of Crohn's disease (CD). The ileal mass was identified as filiform polyposis. After multidisciplinary consultation, she was treated with Ustekinumab, leading to significant symptomatic and endoscopic improvement. The mass was subsequently resected via hybrid ESD and confirmed as an inflammatory polyp. CONCLUSIONS This case reveals that although a patient has no significant symptoms related to CD, FP located at the terminal ileum can initially manifest as CD, highlighting the need for through evaluation to detect underlying IBD. Multidisciplinary collaboration is essential for accurate diagnosis and management. FP can be the "tip of the iceberg" in hidden chronic intestinal inflammation, necessitating careful endoscopic and histologic assessment.
{"title":"Filiform Polyposis of the Terminal Ileum as the Initial Manifestation of Crohn's Disease: A Case Report.","authors":"Muyin Feng, Qili Xiao, Delong Mo, Yuting Xu, Yan Chen, Chuanjian Lu","doi":"10.12659/AJCR.951544","DOIUrl":"10.12659/AJCR.951544","url":null,"abstract":"<p><p>BACKGROUND Filiform polyposis (FP) is a rare pseudopolyp associated with inflammatory bowel disease (IBD), characterized by elongated mucosal projections. It is found primarily in the colon and rectum, and presentation in the ileum is rare. Despite its benign nature, FP can mask underlying chronic intestinal inflammation. CASE REPORT A 52-year-old woman presented with loose stool but no other gastrointestinal symptoms. She was found to have a branched mucosal mass in the terminal ileum and diffuse ulcerations throughout the colorectum. Initial laboratory tests indicated anemia and elevated inflammatory markers. After 3 months of treatment with mesalazine and adjuvant drugs, the symptom of loose stool had improved, but the colonoscopy and imaging examination results show little change from the initial visit. Colonoscopy, imaging, and histopathology supported a diagnosis of Crohn's disease (CD). The ileal mass was identified as filiform polyposis. After multidisciplinary consultation, she was treated with Ustekinumab, leading to significant symptomatic and endoscopic improvement. The mass was subsequently resected via hybrid ESD and confirmed as an inflammatory polyp. CONCLUSIONS This case reveals that although a patient has no significant symptoms related to CD, FP located at the terminal ileum can initially manifest as CD, highlighting the need for through evaluation to detect underlying IBD. Multidisciplinary collaboration is essential for accurate diagnosis and management. FP can be the \"tip of the iceberg\" in hidden chronic intestinal inflammation, necessitating careful endoscopic and histologic assessment.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e951544"},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146132687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jes M Sanders, Matthew Harris, Juan Carlos Caicedo, Steven J Schwulst
BACKGROUND Eisenmenger syndrome presents a unique challenge for the acute care surgeon. Even routine operations such as laparoscopic appendectomy or cholecystectomy become challenging due to the cardiopulmonary physiologic changes and anatomic anomalies associated with Eisenmenger syndrome. The care of these patients can be further complicated by the severity of disease, surgical complexity, and the abnormal anatomy associated with the syndrome. CASE REPORT A 35-year-old patient with Eisenmenger syndrome and abdominal heterotaxy presented with acute cholecystitis. She underwent percutaneous cholecystostomy tube placement during her index hospitalization, which was complicated by atrial fibrillation and a cerebrovascular accident due to air embolism. Three months after presentation, she underwent an uncomplicated open cholecystectomy. She was discharged on post-operative day 5, and her course was notable only for a superficial surgical site infection requiring incision and drainage and antibiotics. CONCLUSIONS Our experience managing acute cholecystitis in a patient with Eisenmenger syndrome, abdominal heterotaxy with interrupted inferior vena cava, and bilateral superior vena cava, highlights critical aspects of care of such patients in the context of routine acute surgical care. Pre-operative planning should include optimization of cardiopulmonary function, an individualized anesthetic plan to maintain systemic vascular resistance, and bailout maneuvers in the event of cardiovascular collapse, such as planning for extracorporeal membrane oxygenation with axillary cannulation in the case of our patient.
{"title":"Management of Acute Cholecystitis in a Patient With Eisenmenger Syndrome and Abdominal Heterotaxy: A Case Report.","authors":"Jes M Sanders, Matthew Harris, Juan Carlos Caicedo, Steven J Schwulst","doi":"10.12659/AJCR.951532","DOIUrl":"10.12659/AJCR.951532","url":null,"abstract":"<p><p>BACKGROUND Eisenmenger syndrome presents a unique challenge for the acute care surgeon. Even routine operations such as laparoscopic appendectomy or cholecystectomy become challenging due to the cardiopulmonary physiologic changes and anatomic anomalies associated with Eisenmenger syndrome. The care of these patients can be further complicated by the severity of disease, surgical complexity, and the abnormal anatomy associated with the syndrome. CASE REPORT A 35-year-old patient with Eisenmenger syndrome and abdominal heterotaxy presented with acute cholecystitis. She underwent percutaneous cholecystostomy tube placement during her index hospitalization, which was complicated by atrial fibrillation and a cerebrovascular accident due to air embolism. Three months after presentation, she underwent an uncomplicated open cholecystectomy. She was discharged on post-operative day 5, and her course was notable only for a superficial surgical site infection requiring incision and drainage and antibiotics. CONCLUSIONS Our experience managing acute cholecystitis in a patient with Eisenmenger syndrome, abdominal heterotaxy with interrupted inferior vena cava, and bilateral superior vena cava, highlights critical aspects of care of such patients in the context of routine acute surgical care. Pre-operative planning should include optimization of cardiopulmonary function, an individualized anesthetic plan to maintain systemic vascular resistance, and bailout maneuvers in the event of cardiovascular collapse, such as planning for extracorporeal membrane oxygenation with axillary cannulation in the case of our patient.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e951532"},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Omar Al Tabaa, Sabrina Hamroun, Khaled Al Tabaa, Roxana Poll, Waad Al Sheikh, Edouard Pertuiset
BACKGROUND Giant cell arteritis (GCA) is the most common large-vessel vasculitis in individuals over age 50 years. Although it typically affects extracranial branches of the carotid artery, central nervous system involvement is rare and can manifest with ischemic stroke. Links between GCA and malignancy have been reported, especially hematologic cancers, but paraneoplastic GCA associated with solid tumors remains exceptional and poorly understood. CASE REPORT We describe a 59-year-old man presenting with temporal headaches, right-hand paresthesia, monocular visual loss, and gait instability. Imaging revealed left thalamic ischemia and bilateral vertebral artery stenosis without atherosclerosis. Examination and Doppler ultrasound supported a diagnosis of GCA with associated polymyalgia rheumatica (PMR), although a temporal artery biopsy was negative. Inflammatory markers were only moderately elevated, consistent with reports of GCA cases with ischemic complications. PET-CT incidentally identified a mediastinal mass, confirmed as small-cell pulmonary neuroendocrine carcinoma. Symptoms improved with corticosteroids, but tapering below 15 mg/day caused relapse, requiring methotrexate. Despite partial oncologic response, brain metastases appeared 8 months later. Follow-up vascular imaging showed regression of arterial stenoses under corticosteroids, arguing against atherosclerosis and supporting the inflammatory nature of the lesions. GCA manifestations remained corticosteroid-dependent throughout follow-up. CONCLUSIONS The simultaneity of GCA and lung neuroendocrine carcinoma, persistence of corticosteroid dependence, and lack of remission despite oncologic response strongly suggest a paraneoplastic mechanism. This case emphasizes the need for heightened suspicion of underlying cancer in patients with atypical, biopsy-negative, or treatment-resistant vasculitis. Recognition of paraneoplastic GCA may improve early cancer detection and influence management decisions at the intersection of rheumatology and oncology.
{"title":"Giant Cell Arteritis/Polymyalgia Rheumatica and Atypical Pulmonary Carcinoid Tumor: A Paraneoplastic Syndrome?","authors":"Omar Al Tabaa, Sabrina Hamroun, Khaled Al Tabaa, Roxana Poll, Waad Al Sheikh, Edouard Pertuiset","doi":"10.12659/AJCR.950346","DOIUrl":"10.12659/AJCR.950346","url":null,"abstract":"<p><p>BACKGROUND Giant cell arteritis (GCA) is the most common large-vessel vasculitis in individuals over age 50 years. Although it typically affects extracranial branches of the carotid artery, central nervous system involvement is rare and can manifest with ischemic stroke. Links between GCA and malignancy have been reported, especially hematologic cancers, but paraneoplastic GCA associated with solid tumors remains exceptional and poorly understood. CASE REPORT We describe a 59-year-old man presenting with temporal headaches, right-hand paresthesia, monocular visual loss, and gait instability. Imaging revealed left thalamic ischemia and bilateral vertebral artery stenosis without atherosclerosis. Examination and Doppler ultrasound supported a diagnosis of GCA with associated polymyalgia rheumatica (PMR), although a temporal artery biopsy was negative. Inflammatory markers were only moderately elevated, consistent with reports of GCA cases with ischemic complications. PET-CT incidentally identified a mediastinal mass, confirmed as small-cell pulmonary neuroendocrine carcinoma. Symptoms improved with corticosteroids, but tapering below 15 mg/day caused relapse, requiring methotrexate. Despite partial oncologic response, brain metastases appeared 8 months later. Follow-up vascular imaging showed regression of arterial stenoses under corticosteroids, arguing against atherosclerosis and supporting the inflammatory nature of the lesions. GCA manifestations remained corticosteroid-dependent throughout follow-up. CONCLUSIONS The simultaneity of GCA and lung neuroendocrine carcinoma, persistence of corticosteroid dependence, and lack of remission despite oncologic response strongly suggest a paraneoplastic mechanism. This case emphasizes the need for heightened suspicion of underlying cancer in patients with atypical, biopsy-negative, or treatment-resistant vasculitis. Recognition of paraneoplastic GCA may improve early cancer detection and influence management decisions at the intersection of rheumatology and oncology.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950346"},"PeriodicalIF":0.7,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND Paraduodenal hernia (PDH) is a rare internal hernia, accounting for 50% to 55% of internal hernias but only 0.2% to 0.9% of intestinal obstructions. Right-sided PDH is less common, occurring in approximately 25% of cases. CASE REPORT This case describes a 33-year-old pregnant woman at 20 weeks 6 days gestation who was admitted with a 15-day history of abdominal distension accompanied by nausea and vomiting. The patient had postprandial exacerbation of intermittent abdominal pain, bilious vomiting, and significant weight loss (5 kg), with a history of similar symptoms during previous pregnancies. Abdominal contrast-enhanced computed tomography revealed clustered bowel loops in the right upper quadrant and medial displacement of the superior mesenteric vein, which is consistent with right-sided PDH complicated by intestinal malrotation. After conservative treatment failed, the patient opted for pregnancy termination followed by laparoscopic surgery. Intraoperative exploration confirmed complete absence of fusion between the ascending mesocolon and the posterior peritoneum, resulting in a wide hernia defect through which bowel loops had herniated into the space lateral to the ascending duodenum. The procedure included reduction of herniated contents, adhesiolysis, and fixation of the ascending mesocolon. The patient's recovery was uneventful, and she was discharged on postoperative day 5. At 3-month follow-up, no abnormalities were noted. CONCLUSIONS Given its nonspecific clinical presentation, PDH is frequently misdiagnosed or diagnosed late. Abdominal computed tomography facilitates early diagnosis and timely intervention, while laparoscopic repair offers favorable outcomes.
{"title":"Paraduodenal Hernia With Intestinal Obstruction During Pregnancy.","authors":"Yuhang You, Fangxin Wan, Guodong Song","doi":"10.12659/AJCR.951298","DOIUrl":"10.12659/AJCR.951298","url":null,"abstract":"<p><p>BACKGROUND Paraduodenal hernia (PDH) is a rare internal hernia, accounting for 50% to 55% of internal hernias but only 0.2% to 0.9% of intestinal obstructions. Right-sided PDH is less common, occurring in approximately 25% of cases. CASE REPORT This case describes a 33-year-old pregnant woman at 20 weeks 6 days gestation who was admitted with a 15-day history of abdominal distension accompanied by nausea and vomiting. The patient had postprandial exacerbation of intermittent abdominal pain, bilious vomiting, and significant weight loss (5 kg), with a history of similar symptoms during previous pregnancies. Abdominal contrast-enhanced computed tomography revealed clustered bowel loops in the right upper quadrant and medial displacement of the superior mesenteric vein, which is consistent with right-sided PDH complicated by intestinal malrotation. After conservative treatment failed, the patient opted for pregnancy termination followed by laparoscopic surgery. Intraoperative exploration confirmed complete absence of fusion between the ascending mesocolon and the posterior peritoneum, resulting in a wide hernia defect through which bowel loops had herniated into the space lateral to the ascending duodenum. The procedure included reduction of herniated contents, adhesiolysis, and fixation of the ascending mesocolon. The patient's recovery was uneventful, and she was discharged on postoperative day 5. At 3-month follow-up, no abnormalities were noted. CONCLUSIONS Given its nonspecific clinical presentation, PDH is frequently misdiagnosed or diagnosed late. Abdominal computed tomography facilitates early diagnosis and timely intervention, while laparoscopic repair offers favorable outcomes.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e951298"},"PeriodicalIF":0.7,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}